Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Medullary Carcinoma”

642 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 642 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT02657551
What this trial is testing

A Study Using Regorafenib as Second or Third Line Therapy in Metastatic Medullary Thyroid Cancer

Who this might be right for
Thyroid Cancer
Dana-Farber Cancer Institute 8
Testing effectiveness (Phase 2)Study completedNCT03947151
What this trial is testing

Efficacy and Tolerance of an Ovarian Stimulation Protocol Combining Follicle Stimulating Hormone (FSH) and Degarelix Acetate in Female Candidates for Fertility Preservation Before Chemotherapy for Breast Cancer

Who this might be right for
Invasive Ductal Breast Carcinoma
Assistance Publique - Hôpitaux de Paris 8
Testing effectiveness (Phase 2)Study completedNCT03037385
What this trial is testing

Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors

Who this might be right for
RET-altered Non Small Cell Lung CancerMedullary Thyroid CancerRET-altered Papillary Thyroid Cancer+37 more
Hoffmann-La Roche 590
Not applicableStudy completedNCT00182728
What this trial is testing

Radiation Therapy During Surgery in Treating Older Women With Invasive Breast Cancer

Who this might be right for
Breast Cancer
UNC Lineberger Comprehensive Cancer Center 89
Large-scale testing (Phase 3)Looking for participantsNCT01185132
What this trial is testing

Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy

Who this might be right for
Breast Cancer
Rocky Mountain Cancer Centers 660
Large-scale testing (Phase 3)Ended earlyNCT00097344
What this trial is testing

The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer

Who this might be right for
Breast NeoplasmsNeoplasms, Hormone-Dependent
Intarcia Therapeutics 842
Testing effectiveness (Phase 2)Active Not RecruitingNCT04280081
What this trial is testing

Selpercatinib (LY3527723) in Participants With Advanced Solid Tumors Including RET Fusion-positive Solid Tumors, Medullary Thyroid Cancer and Other Tumors With RET Activation

Who this might be right for
Solid TumorMedullary Thyroid Cancer
Eli Lilly and Company 77
Not applicableStudy completedNCT00569543
What this trial is testing

Effect of Tamoxifen or an Aromatase Inhibitor on Estrogen Metabolism in Women Treated for Newly Diagnosed Breast Cancer

Who this might be right for
Breast Cancer
University of Nebraska 27
Not applicableStudy completedNCT00898508
What this trial is testing

Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease

Who this might be right for
Breast Cancer
City of Hope Medical Center 563
Testing effectiveness (Phase 2)Study completedNCT02694809
What this trial is testing

The PROMISE Study: Duavee in Women With DCIS

Who this might be right for
Ductal Breast Carcinoma In SituPostmenopausal
Northwestern University 142
Testing effectiveness (Phase 2)Study completedNCT02114658
What this trial is testing

Sorafenib Phase II Study for Japanese Anaplastic or Medullary Thyroid Carcinoma Patients

Who this might be right for
Thyroid Carcinoma
Bayer 18
Testing effectiveness (Phase 2)UnknownNCT01118065
What this trial is testing

Everolimus in Treating Patients With Progressive or Recurrent, Unresectable, or Metastatic Thyroid Cancer

Who this might be right for
Head and Neck Cancer
Leiden University Medical Center 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT04551495
What this trial is testing

Neoadjuvant Study of Targeting ROS1 in Combination With Endocrine Therapy in Invasive Lobular Carcinoma of the Breast (ROSALINE)

Who this might be right for
Invasive Lobular Breast CarcinomaER+ Breast CancerHER2-negative Breast Cancer
Jules Bordet Institute 65
Testing effectiveness (Phase 2)Ended earlyNCT01060345
What this trial is testing

A Pilot Study of Chemo-prevention of Green Tea in Women With Ductal Carcinoma in Situ

Who this might be right for
Ductal Carcinoma in Situ
University of Chicago 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05286801
What this trial is testing

Tiragolumab and Atezolizumab for the Treatment of Relapsed or Refractory SMARCB1 or SMARCA4 Deficient Tumors

Who this might be right for
Atypical Teratoid/Rhabdoid TumorEpithelioid SarcomaKidney Medullary Carcinoma+15 more
National Cancer Institute (NCI) 86
Not applicableLooking for participantsNCT05837767
What this trial is testing

Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

Who this might be right for
Invasive Ductal Breast CarcinomaInvasive Ductal Breast Carcinoma Stage IVLobular Breast Carcinoma+12 more
Memorial Sloan Kettering Cancer Center 26
Not applicableStudy completedNCT00103181
What this trial is testing

Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer

Who this might be right for
Breast Cancer
NSABP Foundation Inc 4,216
Not applicableUnknownNCT01295723
What this trial is testing

Intraoperative Boost Radiotherapy With Electrons (IOERT) Followed By Hypofractionated Whole-Breast Irradiation (WBRT)

Who this might be right for
Invasive Lobular and Ductal Carcinoma
St. Joseph Hospital of Orange 200
Testing effectiveness (Phase 2)Study completedNCT00035243
What this trial is testing

EPO906 Therapy in Patients With Advanced Kidney Cancer

Who this might be right for
Kidney Neoplasms
Novartis Pharmaceuticals 53
Not applicableStudy completedNCT00896857
What this trial is testing

Studying Cells Collected Through Ductal Lavage in Women Undergoing Surgery for Ductal Carcinoma In Situ or Other Breast Cancer

Who this might be right for
Breast Cancer
Wake Forest University Health Sciences 30
Load More Results